tongtamarat

tongtamarat | Joined since 2021-06-11

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

63

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
63
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2021-06-29 15:15 | Report Abuse

(June 9): Pertama Digital Bhd has secured the first four product partners — Trevo, Paywatch, Qoala and Butterfly FX, which will bring expertise and solutions in their respective fields to plug into Pertama Digital’s proposed digital bank.

In a filing with Bursa Malaysia today, Permata Digital said this followed its recent announcements on securing Crowdo Holdings Pte Ltd and INFOPRO Sdn Bhd as consortium partners to apply for a digital banking licence from Bank Negara Malaysia.

The company said in order to build a digital bank that empowers financially underserved Malaysians, it has built strong relationships with existing financial inclusion innovators such as these companies on ethical financial products addressing insurance technology (insurtech), gig economy, and educational technology (edtech).

Stock

2021-06-29 15:10 | Report Abuse

混打疫苖,代表越多品牌疫苖,越有效,大家有大家的市場,這對永大來說是好事。



https://www.sinchew.com.my/content/content_2502722.html?fbclid=IwAR2atYJbEoz9WsmvxjOH8h-6iPLg3-VDqmEG10bqbrNtoUP8MTYRytfnCw4

牛津研究: AZ辉瑞疫苗混打产生更多抗体

(牛津29日综合电)一支由英国牛津大学领导研究的团队近日发现,混打辉瑞和阿利斯康冠病疫苗可以激起保护性免疫反应。

牛津大学亦同时发现,首剂接种阿斯利康疫苗人士若把施打第二剂同款疫苗时间延长至最多45周,可产生较强免疫反应。至于完成接种第二剂阿斯利康疫苗人士相隔半年以上打第三针,也可提升其免疫反应。

掳报道,牛津大学进行的研究比较了辉瑞和阿斯利康疫苗的两剂混合计划,并得出结论,在任何组合中,它们都会产生针对冠病病毒尖峰蛋白的高浓度抗体。

该试验的首席研究员、牛津大学儿科和疫苗学副教授斯内普教授表示,与注射两剂相同的冠病疫苗相比,使用不同的疫苗能产生更高水平的免疫细胞来攻击冠病病毒。他说,目前还不清楚为什么混打疫苗有这种优势,“这是非常耐人寻味的。”

Stock

2021-06-25 20:45 | Report Abuse

lets hav a good rest first, fight again next week

Stock

2021-06-25 20:44 | Report Abuse

香港少了一個對手,有希望嗎?

Stock

2021-06-25 19:53 | Report Abuse

long term investment, no immediate effect

Stock

2021-06-25 11:48 | Report Abuse

人類長期需要打疫苖,永大投資在疫苖研發,是明智的!

https://www.chinapress.com.my/?p=2564956




世卫预料长者等高危群组 或每年要接种疫苗加强剂

(日内瓦25日综合电)全球多国已开疫苗接种,世界卫生组织表示,预计部分最脆弱群组,例如长者等,可能需要每年接种新冠疫苗加强剂,其余群组就每2年打一次加强剂。


据外电引述世卫内部文件指,世卫一份报告提及相关建议,但未有解释如何达致这个结论,报告估计,新的变种病毒基本上会继续出现,疫苗需定期改良,以应付这些变种。

Stock

2021-06-24 20:03 | Report Abuse

LAS VEGAS: Genting Group opens its newest resort tomorrow, a US$4.3 billion (RM18 billion) extravaganza in Las Vegas and the biggest new property on the city’s famous Strip in over a decade.

Resorts World Las Vegas features 3,500 hotel rooms, a 5,000-seat theatre with Celine Dion in residency and a 100,000-square-foot LED screen on the side of one tower. There is also a pop-up store selling clothing from the Kardashian family’s closets and a speak-easy called the Here Kitty Kitty Vice Den.

Stock

2021-06-24 18:54 | Report Abuse

自上周获得合约后,震科(GENETEC,0104,创业板科技)本周节节攀升,今日盘中一度突破7令吉,不断上挑历史新高水平。


该股今日开市扬13仙至6.45令吉,之后股价直往北攀,最高冲至7.04令吉,涨72仙或11%,闭市时,该股报6.69令吉,扬37仙,为十大上升股之一,交投量213万5100股。从5月31日的闭市价3.70令吉计算,单单是6月份至今,该股已涨了80%。

Stock

2021-06-21 01:06 | Report Abuse

https://www.malaysianewslab.com/zh/news_cn/20210618-3/

经销冠病疫苗并非永大集团的唯一目标,该集团的终极目标,是把中国的疫苗研究和生产技术引进我国,在本地设厂研发和生产冠病或其他的疫苗,以让国家和国人用更低的价格,来应付未来对疫苗长期的需要。

永大集团首席执行员拿督巫光伦透露,中国深圳康泰生物制品股份有限公司(康泰生物)在获得中国外交部核准下,已於今年3月30日致函我国首相丹斯里慕尤丁,献议在马来西亚投资巨额设立冠病疫苗研发中心,以“探讨未来在大马研发和生产疫苗,以及技术转移的合作机会”。

如果成事,这将是康泰生物在东南亚设立的第一所冠病疫苗研究和生产中心,而永大集团则会是康泰生物在大马的合作伙伴。

Stock

2021-06-21 01:05 | Report Abuse

guys, what to expect this morning?

Stock

2021-06-19 20:07 | Report Abuse

Low cost carrier AirAsia Group Bhd is seeing a strong comeback this year on the back of vaccines and robust pent up demand for travel.

Group chief executive officer Tan Sri Tony Fernandes reaffirmed his confidence for AirAsia and for airlines world over this year, as there will be a rapid recovery in domestic air travel set to be above 2019 by 2022 with Asia Pacific leading the way, he said, quoting International Air Transport Association (IATA) report.

"Vaccines are working and you only need to look to countries with significant progress in Covid-19 vaccination, such as the United States, the United Kingdom and Israel, where there is a clear correlation between significantly less daily cases and vaccination programmes being rolled out as fast as possible."

Stock